Volume 5, Number 2, Supplement 1 (February 2008)

Cancer Genetics

2

Genetic testing and management of patients with BRCA1/2-positive breast and ovarian cancers

Linda D. Bosserman, MD, FACP

Wilshire Oncology Medical Group, Inc., La Verne, CA

Assessing family history is a critical part of oncology consultations, especially for patients with breast and ovarian cancers. If a patient’s family history indicates an increased risk of inherited malignancies, it’s appropriate to discuss genetic testing with her as part of a comprehensive treatment plan. Oncologists, whether or not they coordinate with a genetic counselor need to be well versed in risk assessment, screening, and its impact on treatment options. As the tools and technology of genetic testing have been developed, key resources have become available to busy oncologists so that they can provide this service with confidence.

FROM THE ADMINISTRATOR'S PERSPECTIVE
Administrative issues in genetic counseling and testing

Raquel Caldera, PA-C

Wilshire Oncology Medical Group, Inc., La Verne, CA

abstract

full text

148 kb

Funding for this publication was provided by Myriad Genetic Laboratories, Inc.

© 2008 by Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.